Urology News Articles

▼ Show details

Search today's latest Urology news articles updated daily summarizing the most recent top clinical literature from over 2,000 peer-reviewed journals, including Journal of Urology, European Urology, The Prostate, and more. Read coverage of the kidney, bladder, penis/urethra and prostate. View article summaries by subspecialty and disease state, including pediatric urology, urologic oncology, kidney stone disease, infections and STDs, urologic imaging, ureteral disorders, voiding and incontinence, infertility, laparoscopy and other surgical techniques in Urology.

New! >> Start your free Urology Board Exam Prep course now.
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

1 Efficacy outcomes by baseline prostate-specific antigen quartile in the AFFIRM trial Full Text European Urology, January 26, 2015    Clinical Article

2 Five-year nationwide follow-up study of active surveillance for prostate cancer Full Text European Urology, January 26, 2015    Clinical Article

3 Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer The Prostate, January 26, 2015    Clinical Article

4 Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel Prostate Cancer & Prostatic Diseases, January 26, 2015    Clinical Article

5 Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? analysis of prostate cancer–specific mortality by nomogram-predicted risks of biochemical recurrence Full Text European Urology, January 26, 2015    Clinical Article

6 The usefulness of diffusion-weighted magnetic resonance imaging in bladder cancer staging and functional analysis Journal of Cancer Research and Therapeutics, January 26, 2015    Clinical Article

7 The impact of pelvic venous pressure on blood loss during open radical cystectomy and urinary diversion: Results from a secondary analysis of a randomized clinical trial The Journal of Urology, January 26, 2015    Clinical Article

8 Exploring the 3 A's of cystectomy access to care for muscle-invasive bladder cancer Urologic Oncology: Seminars and Original Investigations, January 26, 2015

9 Computed tomography criteria for discrimination of adrenal adenomas and adrenocortical carcinomas - analysis of the German ACC registry European Journal of Endocrinology, January 26, 2015    Clinical Article

10 Primary versus secondary adrenal insufficiency: ACTH stimulated aldosterone diagnostic cut-off values by tandem mass spectrometry Clinical Endocrinology, January 26, 2015    Clinical Article

11 Fetal endocrine therapy for congenital adrenal hyperplasia should not be done Best Practice & Research Clinical Endocrinology & Metabolism, January 26, 2015    Review Article

12 Pagetoid spread of bladder urothelial carcinoma to the vagina and vulva Journal of Lower Genital Tract Disease, January 26, 2015    Clinical Article

13 Bladder cancer mortality after spinal cord injury over 4 decades The Journal of Urology, January 26, 2015

14 Intra-sample heterogeneity of sperm DNA methylation Molecular Human Reproduction, January 26, 2015

15 A survey on anticancer effects of artemisinin, iron, miconazole, and butyric acid on 5637 (bladder cancer) and 4T1 (Breast cancer) cell lines Journal of Cancer Research and Therapeutics, January 26, 2015    Clinical Article

Prior Articles

16 Prevention of needle displacement in multifraction high-dose-rate prostate brachytherapy: A prospective volumetric analysis and technical considerations Practical Radiation Oncology, January 23, 2015    Clinical Article

17 Non-inferiority of silodosin 4 mg once daily to twice daily for storage symptoms score evaluated by the International Prostate Symptom Score in Japanese patients with benign prostatic hyperplasia: A multicenter, randomized, parallel-group study International Journal of Urology, January 23, 2015    Clinical Article

18 Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): Final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study The Lancet Oncology, January 23, 2015    Clinical Article

19 Reduction in hospital admissions with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies Urology, January 23, 2015    Clinical Article

20 Intraoperative fluorescence imaging for detection of sentinel lymph nodes and lymphatic vessels during open prostatectomy using indocyanine green The Journal of Urology, January 23, 2015    Clinical Article

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last

Clinical Pearls in Urology

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Highlights in Urology

Chromogranin A staining as a biomarker for prostate adenocarcinoma

As reported in The Prostate, chromogranin A (CgA) staining, an indicator of neuroendocrine differentiation, is associated with decreased biochemical control, clinical failure, increased distant metastases, and decreased cause-specific survival in patients with prostate adenocarcinoma and a GS ≥ 7 (n=285). The median follow-up was 6.5 y. CgA staining was present in 31% of specimens. The 10-y distant metastases rate in specimens with <1% and >1% CgA staining was 8% and 48%, respectively. The 10-y cause-specific survival in specimens with <1% and >1% CgA staining was 95% vs. 76%, respectively.

GALNT4 predicts survival in patients with ccRCC

As reported in the Journal of Urology, N-acetylgalactosaminyltransferase 4 (GALNT4) levels are decreased in tumor specimens from patients with clear cell renal cell carcinoma (ccRCC; n=104) compared to peritumoral specimens. Decreased expression of GALNT4 is associated with poor OS (OR=3.08) and RFS (OR=2.17). Further, GALNT4 is negatively correlated with tumor size, necrosis, and TNM stage.

High expression of MUC1 + HER3 is associated with favorable outcome in bladder cancer patients

As reported in BJU International, elevated co-expression of MUC1 + HER3 was associated with improved survival in patients with bladder cancer. MUC1 alone, or elevated MUC1 + non-elevated HER3, had no prognostic value. Moreover, MUC1 was not predictive of survival, tumor stage, or tumor grade.


Other Topics in Urology

Make smarter career moves with less time.

Sign up for our free job placement service today and have a dedicated career consultant help locate the right physician job for you!
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.
 

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List